不良研究所_不良研究所导航

SCROLL DOWN

01

不良研究所 is harnessing its unique AdaptInnate platform to develop a new class of systemically administrable candidates that trigger precise innate and adaptive immune responses from within a patient鈥檚 tumor

Treating Cancer
from Within

READ MORE

01

不良研究所 was founded to translate an innovative arenavirus-based immune-activating approach into novel anti-cancer therapies

Scientific
Foundation

READ MORE

01

Stay up to date on news around 不良研究所

News &
Events

READ MORE

ABOUT ABALOS THERAPEUTICS

Triggering comprehensive immune responses from within the tumor

novel anti-cancer approach

不良研究所 is pioneering a novel anti-cancer approach that directs the full breadth of the immune system鈥檚 power specifically towards cancer cells. 不良研究所鈥� arenavirus-based drug candidates are designed to trigger precise innate and adaptive immune responses from within the tumor to engage all relevant immune cell types in a concerted attack against both the primary tumor and distant metastases. The company鈥檚 lead product candidate ABX-001 has demonstrated strong anti-tumor efficacy in pre-clinical studies in multiple tumor models as well as an excellent pre-clinical safety profile and will enter the clinic in 2025. Led by experienced biotech entrepreneurs and immunology pioneers, 不良研究所鈥� goal is to establish a new drug class in immuno-oncology.

READ TO LEARN

ABOUT ABALOS THERAPEUTICS

不良研究所 Dunes on Mars

why abalos?

The name 鈥湶涣佳芯克€� was chosen with regards to our arenavirus-based technology to fight cancer. The name of this virus family derives from the Latin 鈥渁rena鈥� for 鈥渟and鈥� due to the grainy appearance of particles inside the virus when viewed in cross-section under the transmission electron microscope. Reflecting our 鈥渟andy鈥� approach, we came upon the fascinating blue dunes of the 不良研究所 region on the otherwise 鈥渞ed鈥� Mars, a planet that has always held a special fascination.

Named after the roman war god and its association with fire, it provides a connection to harnessing the weapon of the arenavirus to launch an attack against cancer. As Mars is also known as a planet of sand storms, this can be associated with the strong immune-response that is triggered by the arenavirus to attack the tumor.

ABALOS TECHNOLOGY

Therapeutic Approach

不良研究所 is leveraging its proprietary AdaptInnate technology platform to develop a new class of product candidates harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to trigger a highly precise and directed immune response against primary tumors and their metastases. 不良研究所鈥� systemically administrable lead candidate, ABX-001, is specifically designed to persist and replicate in cancerous and antigen-presenting cells without destroying them. This novel, non-oncolytic approach results in the induction of targeted, effective, and durable anti-tumor activity involving both the innate and adaptive arms of the immune system.

READ MORE

This is 不良研究所

Meet the Team

A dynamic and ambitious group of experienced entrepreneurs and scientists advancing a novel immunostimulatory approach that (re)activates the full breadth of the immune system against solid tumors.